Major decision aids for prescribing broad empiric therapy targeting MDRP included refence to local guidelines (10 [71%]), local antibiograms (11 [79%]), infectious diseases consult recommendations (9 [64%]), and EMR-based order sets (4 [29%]). This evidence concerns the gene BET1 and infectious disease.